OptimizeRx (NASDAQ:OPRX) Announces Earnings Results

OptimizeRx (NASDAQ:OPRX) announced its quarterly earnings data on Tuesday. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.16), Zacks reports. The firm had revenue of $19.69 million for the quarter, compared to analysts’ expectations of $18.66 million. OptimizeRx had a negative return on equity of 6.96% and a negative net margin of 23.10%. During the same quarter in the previous year, the company posted ($0.34) EPS.

OptimizeRx Price Performance

OPRX stock traded down $0.16 during midday trading on Friday, reaching $12.69. 18,969 shares of the company’s stock traded hands, compared to its average volume of 132,442. The company has a current ratio of 2.88, a quick ratio of 3.04 and a debt-to-equity ratio of 0.26. OptimizeRx has a fifty-two week low of $6.92 and a fifty-two week high of $16.65. The business has a 50-day moving average price of $11.30 and a two-hundred day moving average price of $12.30.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Royal Bank of Canada restated an “outperform” rating and set a $17.00 target price on shares of OptimizeRx in a report on Monday, April 1st. JMP Securities raised their price target on shares of OptimizeRx from $15.00 to $16.00 and gave the stock a “market outperform” rating in a research note on Wednesday. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $13.00 price target on shares of OptimizeRx in a research note on Wednesday. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $16.00.

OptimizeRx Company Profile

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow.